US Stock MarketDetailed Quotes

MIRA MIRA Pharmaceuticals

Watchlist
  • 1.060
  • +0.060+6.00%
Close Dec 20 16:00 ET
  • 1.090
  • +0.030+2.83%
Post 20:01 ET
17.55MMarket Cap-1.53P/E (TTM)

MIRA Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-34.13%2.08M
78.38%1.73M
32.01%1.77M
20.97%8.53M
126.78%3.06M
74.75%3.16M
-59.92%970.22K
-8.96%1.34M
227.48%7.05M
1.35M
Selling and administrative expenses
-52.71%1.01M
4.20%1.12M
63.77%1.01M
117.22%6.5M
5,067.33%2.67M
191.39%2.14M
-32.65%1.07M
-0.49%614.24K
288.53%2.99M
--51.66K
-General and administrative expense
-52.71%1.01M
4.20%1.12M
63.77%1.01M
117.22%6.5M
5,067.33%2.67M
191.39%2.14M
-32.65%1.07M
-0.49%614.24K
288.53%2.99M
--51.66K
Research and development costs
5.14%1.07M
708.26%614.46K
180.66%762.28K
-33.11%1.57M
-56.25%387.12K
42.00%1.02M
-137.50%-101.02K
-43.30%271.61K
243.56%2.35M
--884.76K
Other operating expenses
----
----
----
-73.39%453.55K
--0
----
----
20.98%453.55K
144.32%1.7M
--411.3K
Operating profit
34.13%-2.08M
-78.38%-1.73M
-32.01%-1.77M
-20.97%-8.53M
-126.78%-3.06M
-74.75%-3.16M
59.92%-970.22K
8.96%-1.34M
-227.48%-7.05M
-1.35M
Net non-operating interest income expense
108.83%37.75K
113.31%39.4K
3,149.97%50.42K
-33,619.94%-3.46M
-154,544.45%-2.73M
-18,440.62%-427.73K
-12,681.30%-295.89K
57.20%-1.65K
57.95%-10.25K
-1.77K
Non-operating interest income
----
--39.4K
----
----
----
----
----
----
----
----
Non-operating interest expense
----
----
----
33,619.94%3.46M
----
----
12,681.30%295.89K
----
-57.95%10.25K
--1.77K
Total other finance cost
-108.83%-37.75K
----
-3,149.97%-50.42K
----
----
--427.73K
----
--1.65K
----
----
Other net income (expense)
Income before tax
43.03%-2.04M
-33.58%-1.69M
-28.09%-1.72M
-69.77%-11.98M
-328.86%-5.79M
-98.15%-3.59M
47.75%-1.27M
9.08%-1.34M
-224.29%-7.06M
-1.35M
Income tax
Net income
43.03%-2.04M
-33.58%-1.69M
-28.09%-1.72M
-69.77%-11.98M
-328.86%-5.79M
-98.15%-3.59M
47.75%-1.27M
9.08%-1.34M
-224.29%-7.06M
-1.35M
Net income continuous Operations
43.03%-2.04M
-33.58%-1.69M
-28.09%-1.72M
-69.77%-11.98M
-328.86%-5.79M
-98.15%-3.59M
47.75%-1.27M
9.08%-1.34M
-224.29%-7.06M
---1.35M
Minority interest income
Net income attributable to the parent company
43.03%-2.04M
-33.58%-1.69M
-28.09%-1.72M
-69.77%-11.98M
-328.86%-5.79M
-98.15%-3.59M
47.75%-1.27M
9.08%-1.34M
-224.29%-7.06M
-1.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
43.03%-2.04M
-33.58%-1.69M
-28.09%-1.72M
-69.77%-11.98M
-328.86%-5.79M
-98.15%-3.59M
47.75%-1.27M
9.08%-1.34M
-224.29%-7.06M
-1.35M
Basic earnings per share
46.15%-0.14
-28.11%-0.11
-20.00%-0.12
-60.95%-0.64
-415.03%-0.3915
-154.88%-0.26
37.09%-0.0859
0.04%-0.1
-169.38%-0.3976
-0.076
Diluted earnings per share
46.15%-0.14
-28.11%-0.11
-20.00%-0.12
-60.95%-0.64
-415.03%-0.3915
-154.88%-0.26
37.09%-0.0859
0.04%-0.1
-169.38%-0.3976
-0.076
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -34.13%2.08M78.38%1.73M32.01%1.77M20.97%8.53M126.78%3.06M74.75%3.16M-59.92%970.22K-8.96%1.34M227.48%7.05M1.35M
Selling and administrative expenses -52.71%1.01M4.20%1.12M63.77%1.01M117.22%6.5M5,067.33%2.67M191.39%2.14M-32.65%1.07M-0.49%614.24K288.53%2.99M--51.66K
-General and administrative expense -52.71%1.01M4.20%1.12M63.77%1.01M117.22%6.5M5,067.33%2.67M191.39%2.14M-32.65%1.07M-0.49%614.24K288.53%2.99M--51.66K
Research and development costs 5.14%1.07M708.26%614.46K180.66%762.28K-33.11%1.57M-56.25%387.12K42.00%1.02M-137.50%-101.02K-43.30%271.61K243.56%2.35M--884.76K
Other operating expenses -------------73.39%453.55K--0--------20.98%453.55K144.32%1.7M--411.3K
Operating profit 34.13%-2.08M-78.38%-1.73M-32.01%-1.77M-20.97%-8.53M-126.78%-3.06M-74.75%-3.16M59.92%-970.22K8.96%-1.34M-227.48%-7.05M-1.35M
Net non-operating interest income expense 108.83%37.75K113.31%39.4K3,149.97%50.42K-33,619.94%-3.46M-154,544.45%-2.73M-18,440.62%-427.73K-12,681.30%-295.89K57.20%-1.65K57.95%-10.25K-1.77K
Non-operating interest income ------39.4K--------------------------------
Non-operating interest expense ------------33,619.94%3.46M--------12,681.30%295.89K-----57.95%10.25K--1.77K
Total other finance cost -108.83%-37.75K-----3,149.97%-50.42K----------427.73K------1.65K--------
Other net income (expense)
Income before tax 43.03%-2.04M-33.58%-1.69M-28.09%-1.72M-69.77%-11.98M-328.86%-5.79M-98.15%-3.59M47.75%-1.27M9.08%-1.34M-224.29%-7.06M-1.35M
Income tax
Net income 43.03%-2.04M-33.58%-1.69M-28.09%-1.72M-69.77%-11.98M-328.86%-5.79M-98.15%-3.59M47.75%-1.27M9.08%-1.34M-224.29%-7.06M-1.35M
Net income continuous Operations 43.03%-2.04M-33.58%-1.69M-28.09%-1.72M-69.77%-11.98M-328.86%-5.79M-98.15%-3.59M47.75%-1.27M9.08%-1.34M-224.29%-7.06M---1.35M
Minority interest income
Net income attributable to the parent company 43.03%-2.04M-33.58%-1.69M-28.09%-1.72M-69.77%-11.98M-328.86%-5.79M-98.15%-3.59M47.75%-1.27M9.08%-1.34M-224.29%-7.06M-1.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 43.03%-2.04M-33.58%-1.69M-28.09%-1.72M-69.77%-11.98M-328.86%-5.79M-98.15%-3.59M47.75%-1.27M9.08%-1.34M-224.29%-7.06M-1.35M
Basic earnings per share 46.15%-0.14-28.11%-0.11-20.00%-0.12-60.95%-0.64-415.03%-0.3915-154.88%-0.2637.09%-0.08590.04%-0.1-169.38%-0.3976-0.076
Diluted earnings per share 46.15%-0.14-28.11%-0.11-20.00%-0.12-60.95%-0.64-415.03%-0.3915-154.88%-0.2637.09%-0.08590.04%-0.1-169.38%-0.3976-0.076
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--
Trending US Stocks
Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Symbol Mini Chart % Chg
Ermenegildo Zegna NV
ZGN
+6.16%
DexCom
DXCM
+5.57%
New Fortress Energy
NFE
+5.37%
Workday
WDAY
+2.33%
eBay
EBAY
+1.66%

Unlock the Full List